At both the mid-childhood and early teen visits, we used fasting blood to measure plasma glucose enzymatically, and insulin using an electrochemiluminescence immunoassay (Roche Diagnostics, Indianapolis, IN). Serum total cholesterol, triglycerides, and high-density lipoprotein (HDL) were measured enzymatically with correction for endogenous glycerol. We measured plasma leptin and adiponectin concentrations with a radioimmunoassay (Linco Research, St Charles, MO). We used an immunoturbidimetric high-sensitivity assay on a Hitachi 911 analyzer to determine C-reactive protein (CRP) concentrations (Roche Diagnostics, Indianapolis, IN). Plasma interleukin-6 (IL-6) was measured by ultrasensitive enzyme-linked immunosorbent assay (ELISA).
challenge, followed by a 100-g 3-hour oral glucose test for women with abnormal results. Based on results of the 2-stage testing, we categorized women as having GDM, impaired glucose tolerance, isolated hyperglycemia, or normoglycemia (3) . We obtained birth characteristics, including sex and delivery date, from medical records. Mothers reported on breastfeeding duration in postpartum questionnaires.
At the mid-childhood and early teen visits, RAs measured children's weight (kg) using an electronic scale (Tanita Corporation of America, Inc., Arlington Heights, IL) and height (cm) with a calibrated stadiometer (Shorr Productions, Olney, MD). We used these values to calculate BMI, standardized it as percentile using the Centers for Disease Control growth reference (4), and categorized participants as normal weight (5 th to <85 th percentile, but also included 4 children with BMI <5 th percentile), overweight (85 th to <95 th percentile), and obese (≥95 th percentile). At the mid-childhood research visit, mothers reported on pubarchal/pubertal phenotype based on appearance of body hair, breast development for girls, and body hair, facial hair, and deepening of voice for boys on a scale of 1 (no development) to 4 (full development) (5) . For the analysis, we combined the characteristics as an ordinal summary score of breast development and body hair for girls, and the mean of deepening of voice, facial hair, and body hair for boys for use as a covariate in multivariable models, as well as dichotomized as prepubertal (puberty score=1) vs. pubertal (puberty score>1) for stratified analyses.
Untargeted metabolomics profiling
For untargeted metabolomics profiling, we sent fasting plasma samples collected at the mid-childhood visit to Metabolon Inc. (Durham, NC, USA). Samples were prepared using the automated MicroLab STAR® liquid handling machine from Hamilton Robotics, which employs and mixed the samples for 5 minutes on a Geno/Grinder 2000 (Glen Mills, Inc.), followed by brief placement on a TurboVap® (Zymark) to remove the organic solvent.
Next, sample extraction and ultrahigh performance liquid chromatography (UPLC) was carried out as previously described (6) . The liquid chromatography (LC)/MS of the platform was based on a Waters ACQUITY UPLC and a Thermo-Finnigan linear trap quadrupole mass spectrometer, which consisted of an electrospray ionization source and linear ion-trap mass analyzer. The sample extract was reconstituted in acidic or basic LC-compatible solvents, each of which contained 8 or more injection standards at fixed concentrations to ensure injection and chromatographic consistency. One aliquot each was analyzed using a reverse-phase positive ion method for polar compounds, a reverse-phase positive ion method for lipid compounds, a reverse-phase negative ion method, and a negative ion method for hydrophilic compounds. The MS analysis alternated between MS and data-dependent MS/MS scans using dynamic exclusion.
Raw data files are archived and extracted as described below.
For quality assurance/quality control (QA/QC) purposes, extracts of a pool created from a small aliquot of the experimental samples and process blanks were included with each day's analysis. The QC samples were spaced evenly among the injections and all experimental samples, and randomly distributed them throughout the run. A selection of QC compounds were added to every sample for chromatographic alignment, including those under test. These
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Finally, the raw data were extracted and compound peaks were identified using Metabolon's hardware and software. Compounds were identified via comparison to library entries of purified standards or recurrent unknown entities. More than 4000 commercially available purified standard compounds have been acquired and registered into Laboratory Information Management System (LIMS) for distribution to both the LC and GC platforms for determination of their analytical characteristics.
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